The focus was on digital health, artificial intelligence, prevention, personalized and precision medicine, and longevity, marking a significant milestone in Abu Dhabi’s mission to advance health and well-being for all.
M42 and Juvenescence will work together to identify and develop a pipeline of AI-enabled therapeutics to extend healthy human lifespan and improve treatments for life-threatening and chronic diseases.